Corneal Implants Market size was valued at USD 439.34 million in 2023 and is poised to cross USD 1.01 billion by the end of 2036, expanding at more than 6.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of corneal implants is estimated at USD 462.54 million.
The growth of the market can be attributed to rise in aging population with chronic diseases and increasing prevalence of ophthalmic diseases like cataract, glaucoma, infectious keratitis, Fuchs dystrophy, corneal scarring, etc. leading to corneal blindness. According to World report on vision by the World Health Organization (WHO), it was estimated that, as of 2019, about 2.2 billion people in the world had a vision impairment.
Furthermore, the growing new innovations and advancements in ophthalmology, including artificial corneal regeneration by developing novel biomaterial and minute donor cell-based regenerative implants are driving the demand for corneal transplantations.
However, the development cost of ophthalmology devices is high which makes the surgical procedures expensive for patients. This is a key factor which is expected to restraint the market growth. Moreover, rise in concerns regarding the risks associated with corneal implants is further expected to hamper the growth of the market.
Growth Drivers
Challenges
|
2023 |
|
|
Forecast Year |
2024–2036 |
|
CAGR |
6.6% |
|
Base Year Market Size (2023) |
USD 439.34 million |
|
Forecast Year Market Size (2036) |
USD 1.01 billion |
|
Regional Scope |
|
The corneal implants market is segmented by transplant type into anterior lamellar keratoplasty, penetrating keratoplasty, and endothelial keratoplasty, out of which, the endothelial keratoplasty segment is anticipated to hold the largest share of the market over the forecast period. For instance, in the United States, over 30,000 endothelial keratoplasties were performed in 2021. It is a common method for the treatment of Fuchs’ dystrophy, which is prevalent among the geriatric population. Moreover, this method helps in faster and better visual restoration with decreased risk of infection and accidents to the eye surface, which is also a factor expected to propel the growth of the segment.
On the basis of tissue type, the market is segmented into artificial cornea and human donor cornea, between which artificial cornea segment is estimated to witness fastest growth during the forecast period owing to the shortage of donor tissue. In addition to that, increasing bio-engineered artificial corneas and innovative procedures for artificial corneal crafting are further expected to drive the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
Tissue Type |
|
|
Transplant Type |
|
|
End User |
|
Regionally, the corneal implants market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is likely to hold largest revenue share by 2036, owing to large number of manufacturers for corneal implant devices, and increasing research and development activities bringing significant innovative procedures
The market in Europe region is expected to witness noteworthy growth over the forecast period owing to increasing government emphasized organ donation programs and policies. This region is also leading in innovative treatment options and prevention strategies which is also anticipated to drive the market growth.
In the Asia Pacific region, the market is estimated to grow at the highest rate on the back of prevailing chronic diseases, such as diabetes, diabetic retinopathy, and obesity, that can lead to eye diseases. For instance, China has the highest number of diabetics in the world, with over 140 million people suffering from the disease, as of 2021.
July 2021: Researchers at Cardiff University in United Kingdom co-developed fully synthetic corneal implants which can resolve the corneal tissue shortage and associated immune rejection issues faced by traditional corneal transplants.
January 2021: An Israeli start-up, CorNeat Vision, successfully conducted an artificial cornea transplant procedure that helped a 78-years-old bilaterally blind man regain eye sight.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?